Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Gains from Sales and Divestitures (2017 - 2022)

Usana Health Sciences (USNA) has disclosed Gains from Sales and Divestitures for 6 consecutive years, with $3000.0 as the latest value for Q1 2022.

  • Quarterly Gains from Sales and Divestitures rose 50.0% to $3000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Jan 2022, up 50.0% year-over-year, with the annual reading at $3000.0 for FY2022, 50.0% up from the prior year.
  • Gains from Sales and Divestitures for Q1 2022 was $3000.0 at Usana Health Sciences, up from $2000.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $59000.0 in Q4 2019, with the low at $2000.0 in Q1 2021.
  • Average Gains from Sales and Divestitures over 4 years is $22250.0, with a median of $14000.0 recorded in 2018.
  • The sharpest move saw Gains from Sales and Divestitures soared 150.0% in 2018, then tumbled 96.61% in 2021.
  • Over 4 years, Gains from Sales and Divestitures stood at $25000.0 in 2018, then skyrocketed by 136.0% to $59000.0 in 2019, then crashed by 96.61% to $2000.0 in 2021, then surged by 50.0% to $3000.0 in 2022.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $3000.0, $2000.0, and $59000.0 for Q1 2022, Q1 2021, and Q4 2019 respectively.